Fennec Pharmaceuticals (NASDAQ: FENC) reported Q3 EPS of ($0.02), $0.09 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $12.5 million versus the consensus estimate of $13.37 million.

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.